Year 2017: top* 10 papers with the highest R-portion

Topic: Diagnosis and Treatment of Bladder Cancer

* The top 5% of entries has been removed to reduce statistical anomalies. Further fine-tuning, filtering, and error cleaning are in progress.

Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic

YCR = 2017 / 245 /  8.32 

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachu...

YCR = 2017 / 262 /  8.30 

Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, ph...

YCR = 2017 / 296 /  7.95 

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets

YCR = 2017 / 265 /  7.74 

Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification

YCR = 2017 / 261 /  7.47 

Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

YCR = 2017 / 208 /  6.96 

Guideline of guidelines: non‐muscle‐invasive bladder cancer

YCR = 2017 / 196 /  6.36 

Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic ana...

YCR = 2017 / 256 /  6.05 

Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency

YCR = 2017 / 221 /  6.04 

DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

YCR = 2017 / 220 /  6.02